desipramine has been researched along with ar-c239 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callado, LF; Gabilondo, AM; Meana, JJ | 1 |
| Hopwood, SE; Stamford, JA | 1 |
2 other study(ies) available for desipramine and ar-c239
| Article | Year |
|---|---|
Differential modulation of alpha2-adrenoceptor subtypes in rat kidney by chronic desipramine treatment.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Binding, Competitive; Clorgyline; Desipramine; Epinephrine; Idazoxan; Imidazoles; In Vitro Techniques; Indoles; Isoindoles; Isoquinolines; Kidney; Kinetics; Male; Monoamine Oxidase Inhibitors; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2 | 1999 |
Noradrenergic modulation of serotonin release in rat dorsal and median raphé nuclei via alpha(1) and alpha(2A) adrenoceptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Desipramine; Dexmedetomidine; Electric Stimulation; Electrophysiology; Imidazoles; In Vitro Techniques; Indoles; Isoindoles; Isoquinolines; Male; Norepinephrine; Phenylephrine; Piperazines; Prazosin; Raphe Nuclei; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Serotonin | 2001 |